The significance of comorbidity and age in radical prostatectomy;Bedeutung von komorbidität und alter bei der radikalen prostatektomie

Urologe - Ausgabe A

Volumn 43, Issue 8, 2004, Pages 935-941

  Wirth, M ^a   Frohner M ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Charlson score; Comorbidity; Preoperative cardiopulmonary risk prediction; Prostate cancer; Radical prostatectomy

Indexed keywords

AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CHARLSON SCORE; COMORBIDITY; DISEASE CLASSIFICATION; GLEASON SCORE; HUMAN; MORTALITY; OUTCOMES RESEARCH; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SURVIVAL TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 4544274026     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-004-0640-4     Document Type: Article

References (32)

1. Yates JW (2001) Comorbidity considerations in geriatric oncology research. CA Cancer J Clin 51:329-336
2. Yancik R, Ganz PA, Varricchio CG, Conley B (2001) Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 19:1147-1151
3. Froehner M (2003) Re: Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension. Urol 170:1954
4. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 56:221-229
5. Coebergh JWW, Janssen-Heijnen MLG, Post PN, Razenberg PPA (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the Southeastern part of The Netherlands in 1993-1996. J Clin Epidemiol 52:1131-1136
6. Wirth MP, Froehner M (2000) Comorbidity in prostate cancer. Aging Male 3:132-136
7. Repetto L, Fratino L, Audisio RA et al. (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group Performance Status in elderly cancer patients: An Italian Group for Geriatric Oncology Study. J Clin Oncol 20:494-502
8. Jani AB, Hellmann S (2003) Early prostate cancer: clinical decision making. Lancet 361:1045-1053
9. Catalona WJ, Ramos GR, Carvalhal GF (1999) Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin 49:282-286
10. Wirth M, Fröhner M (2000) Diagnostik und individualisierte Therapie des lokoregionären Prostatakarzinoms. Urologe [A] 39:578-587
11. Froehner M, Litz R, Manseck A, Hakenberg OW, Leike S, Albrecht DM, Wirth MP (2001) Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomy. Urol Int 67:283-288
12. Dillioglugil Ö, Leibman BD, Leibman, NS, Kattan MW, Rosas AL, Scardino PT (1997) Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157:1760-1767
13. Rosenblum N, Lepor H (2001) Radical retropubic prostatectomy. Preoperative management. Urol Clin North Am 28:499-507
14. Noldus J, Huland H (2003) Die operative Therapie des Prostatakarzinoms. Onkologie 26:6-12
15. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J (1996) THe impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156:127-132
16. Barry MJ, Albertsen PC, Bagshaw MA et al. (2001) Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy,or expectant management: a retrospective analysis. Cancer 91:2302-2314
17. Froehner M, Koch R, Litz R, Heller A, Oehlschlaeger S, Wirth MP (2003) Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology 62:698-701
18. Fowler JE, Terrell FL, Renfroe DL (1996) Co-Morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol 156:1714-1718
19. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980
20. Piccirillo JK (2000) Importance of comorbidity in head and neck cancer. Laryngoscope 110:593-602
21. Post PN, Hansen BE, Kil PJM, Janssen-Heijnen MLG, Coebergh JWW (2001) The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study. BJU International 87:821-826
22. Fowler JE, Bigler SA, White PC, Duncan WL (2002) Hormone therapy for locally advanced prostate cancer. J Urol 168:546-549
23. Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H (2002) Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 168:525-529
24. Froehner M, Koch R, Litz R, Haase M, Oehlschlaeger S, Wirth MP (2004) Comparison of the prognostic significance of tumor-related and comorbidity-related predictors of overall mortality after radical prostatectomy. J Urol (Abstract, in press)
25. Extermann M (2000) Measurement and impact of Comorbidity in older cancer patients. Crit Rev Oncol Hematol 35:181-200
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373-383
27. Albertsen PC, Hanley JA, Gleason DF, Barry MJ (1998) Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 280:975-980
28. Froehner M, Koch R, Litz R et al. (2003) Preoperative cardiopulmonary risk assessment as predictor of early non-cancer and overall mortality after radical prostatectomy. Urology 61:596-600
29. Reid BC, Alberg AJ, Klassen AC, Koch WM, Samet JM (2001) The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck 23:985-994
30. Froehner M, Koch R, Litz R, Oehlschlaeger S, Wirth MP (2004) Which conditions contributing to the Charlson score predict survival after radical prostatectomy? J Urol 171:697-699
31. http://www.asahq.org/Profinfo/PhysicalStatus.html
32. http://www.cochranfoundation.com/docs/nyha-class. htm